XML 17 R5.htm IDEA: XBRL DOCUMENT v3.26.1
Condensed Consolidated Statements of Stockholders’ Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Gain (Loss)
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2024   54,718      
Beginning balance at Dec. 31, 2024 $ 402,220 $ 0 $ 948,091 $ 114 $ (545,985)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock under stock plans (in shares)   560      
Issuance of common stock under stock plans 1,298   1,298    
Stock-based compensation expense 10,267   10,267    
Foreign currency translation adjustment 109     109  
Net loss (24,737)       (24,737)
Ending balance (in shares) at Mar. 31, 2025   55,278      
Ending balance at Mar. 31, 2025 $ 389,157 $ 0 959,656 223 (570,722)
Beginning balance (in shares) at Dec. 31, 2025 56,323 56,323      
Beginning balance at Dec. 31, 2025 $ 365,870 $ 0 1,007,390 37 (641,557)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock under stock plans (in shares)   574      
Issuance of common stock under stock plans 222   222    
Stock-based compensation expense 13,269   13,269    
Foreign currency translation adjustment (56)     (56)  
Net loss $ (31,638)       (31,638)
Ending balance (in shares) at Mar. 31, 2026 56,897 56,897      
Ending balance at Mar. 31, 2026 $ 347,667 $ 0 $ 1,020,881 $ (19) $ (673,195)